BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
Frequently asked questions
What sector does BRAIN Biotech AG (BNN) operate in?
BRAIN Biotech AG belongs to the Healthcare sector and operates in the Specialty Chemicals industry.
What is BRAIN Biotech AG (BNN) current stock price?
As of the latest data, BRAIN Biotech AG stock price is €2.76, with a previous close of €2.73. BRAIN Biotech AG gained €0.03 in the last trading session, representing a 1.1% increase.
What is BRAIN Biotech AG (BNN) current market capitalization?
BRAIN Biotech AG market cap is approximately 60.30 million.
What is BRAIN Biotech AG (BNN) Earnings Per Share (EPS)?
The trailing EPS is -€0.64, and the forward EPS is -€0.40.
What is BRAIN Biotech AG (BNN) EBITDA?
BRAIN Biotech AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.13 million.
Does BRAIN Biotech AG (BNN) pay dividends?
No. BRAIN Biotech AG does not pay a dividend.
What is BRAIN Biotech AG (BNN) beta (volatility) score?
BRAIN Biotech AG has a beta of 0.584, indicating lower volatility than the overall market.